These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10965218)

  • 21. Elevated plasma phenylalanine concentrations may adversely affect bone status of phenylketonuric mice.
    Yannicelli S; Medeiros DM
    J Inherit Metab Dis; 2002 Sep; 25(5):347-61. PubMed ID: 12408184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma thiols and their determinants in phenylketonuria.
    Colomé C; Artuch R; Sierra C; Brandi N; Lambruschini N; Campistol J; Vilaseca MA
    Eur J Clin Nutr; 2003 Aug; 57(8):964-8. PubMed ID: 12879091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune status of children with phenylketonuria.
    Gropper SS; Chaung HC; Bernstein LE; Trahms C; Rarback S; Weese SJ
    J Am Coll Nutr; 1995 Jun; 14(3):264-70. PubMed ID: 8586776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carnitine status in early-treated children, adolescents and young adults with phenylketonuria on low phenylalanine diets.
    Weigel C; Kiener C; Meier N; Schmid P; Rauh M; Rascher W; Knerr I
    Ann Nutr Metab; 2008; 53(2):91-5. PubMed ID: 18946205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of dietary aspartame on plasma concentrations of phenylalanine and tyrosine in normal and homozygous phenylketonuric patients.
    Mackey SA; Berlin CM
    Clin Pediatr (Phila); 1992 Jul; 31(7):394-9. PubMed ID: 1617863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Event-related potential correlates of selective processing in early- and continuously-treated children with phenylketonuria: effects of concurrent phenylalanine level and dietary control.
    de Sonneville LM; Huijbregts SC; van Spronsen FJ; Verkerk PH; Sergeant JA; Licht R
    Mol Genet Metab; 2010; 99 Suppl 1():S10-7. PubMed ID: 20123462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating serum phenylalanine concentrations and the effect of arginine infusion on plasma levels of growth hormone and insulin in treated phenylketonuric children.
    Rosskamp R; Mallmann R; Liappis N; Soetadjii S
    Acta Endocrinol (Copenh); 1987 Apr; 114(4):483-7. PubMed ID: 3554869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenylketonuria. The in vivo hydroxylation rate of phenylalanine into tyrosine is decreased.
    van Spronsen FJ; Reijngoud DJ; Smit GP; Nagel GT; Stellaard F; Berger R; Heymans HS
    J Clin Invest; 1998 Jun; 101(12):2875-80. PubMed ID: 9637722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum levels of neural protein S-100B in phenylketonuria.
    Schulpis KH; Kariyannis C; Papassotiriou I
    Clin Biochem; 2004 Jan; 37(1):76-9. PubMed ID: 14675567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of prepotent responding and attentional flexibility in treated phenylketonuria.
    Huijbregts S; de Sonneville L; Licht R; Sergeant J; van Spronsen F
    Dev Neuropsychol; 2002; 22(2):481-99. PubMed ID: 12537335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is there a relationship between plasma phenylalanine and cholesterol in phenylketonuric patients under dietary treatment?
    Colomé C; Artuch R; Lambruschini N; Cambra FJ; Campistol J; Vilaseca M
    Clin Biochem; 2001 Jul; 34(5):373-6. PubMed ID: 11522273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors affecting the variation in plasma phenylalanine in patients with phenylketonuria on diet.
    MacDonald A; Rylance G; Hall SK; Asplin D; Booth IW
    Arch Dis Child; 1996 May; 74(5):412-7. PubMed ID: 8669956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. L-Phenylalanine concentration in blood of phenylketonuria patients: a modified enzyme colorimetric assay compared with amino acid analysis, tandem mass spectrometry, and HPLC methods.
    De Silva V; Oldham CD; May SW
    Clin Chem Lab Med; 2010 Sep; 48(9):1271-9. PubMed ID: 20604724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of blood phenylalanine levels and IQ in children with phenylketonuria.
    Anastasoaie V; Kurzius L; Forbes P; Waisbren S
    Mol Genet Metab; 2008; 95(1-2):17-20. PubMed ID: 18703366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study.
    Schindeler S; Ghosh-Jerath S; Thompson S; Rocca A; Joy P; Kemp A; Rae C; Green K; Wilcken B; Christodoulou J
    Mol Genet Metab; 2007 May; 91(1):48-54. PubMed ID: 17368065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recommendations for protein and amino acid intake in phenylketonuric patients.
    Cockburn F; Clark BJ
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S125-9. PubMed ID: 8828627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response of patients with phenylketonuria in the US to tetrahydrobiopterin.
    Matalon R; Michals-Matalon K; Koch R; Grady J; Tyring S; Stevens RC
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S17-21. PubMed ID: 16143554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimized loading test to evaluate responsiveness to tetrahydrobiopterin (BH4) in Brazilian patients with phenylalanine hydroxylase deficiency.
    Nalin T; Perry ID; Sitta A; Vargas CR; Saraiva-Pereira ML; Giugliani R; Blau N; Schwartz IV
    Mol Genet Metab; 2011; 104 Suppl():S80-5. PubMed ID: 22014474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma phenylalanine concentrations are associated with hepatic iron content in a murine model for phenylketonuria.
    Gropper SS; Yannicelli S; White BD; Medeiros DM
    Mol Genet Metab; 2004 May; 82(1):76-82. PubMed ID: 15110326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.
    Trefz FK; Blau N
    Pediatrics; 2003 Dec; 112(6 Pt 2):1566-9. PubMed ID: 14654666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.